HLA class III genes involvement in Kawasaki disease: a case-control study in Caucasian population

Elisa Maggioli1, Chiara Boiocchi, Michele Zorzetto

  • 1Laboratory of Immunogenetics, Department of Biology & Biotechnology "L.Spallanzani", University of Pavia, Pavia, Italy.

Insights

Genetic analysis of Kawasaki disease (KD) reveals significant variations in specific gene polymorphisms, particularly within the Tumor Necrosis Factor (TNF) and Heat Shock Protein (HSPA) genes. These findings suggest a potential genetic link to KD susceptibility.

Area of Science:

  • Immunogenetics
  • Pediatric Rheumatology
  • Molecular Biology

Background:

  • Kawasaki disease (KD) is an acute febrile vasculitis affecting young children, with unknown etiological factors.
  • Clinical variability in KD has hindered the identification of causative agents.
  • Emerging evidence highlights the roles of genetics and immune system dysregulation in KD pathogenesis.

Purpose of the Study:

  • To investigate the association between functional polymorphisms in Human Leukocyte Antigen (HLA) class III genes and Kawasaki disease susceptibility.
  • To analyze genetic variations in AGER, TNF, HSPA1A, HSPA1B, and HSPA1L genes in Caucasian KD patients and healthy controls.

Main Methods:

  • Genomic DNA was analyzed from 74 Caucasian KD cases and 440 healthy controls.
  • Functional polymorphisms in AGER, TNF, HSPA1A, HSPA1B, and HSPA1L genes were characterized.
  • Allele, genotype, and haplotype frequencies were compared using chi-squared and Fisher's exact tests.

Main Results:

  • Significant deviations were observed in TNF (-308 and -238) and HSPA1A (+190), HSPA1L (+2437) polymorphism genotype and allele frequencies between KD patients and controls.
  • A statistically significant decrease in the CG haplotype for TNF -238 and HSPA1L was noted in KD patients.
  • Specific genotypes (TNF -308 GG, TNF -238 AA, HSPA1A +190 GC, HSPA1L +2437 TT/TC) and alleles (HSPA1L T/C) showed significant associations with KD.

Conclusions:

  • The study suggests a potential involvement of the HLA class III region in Kawasaki disease susceptibility.
  • Specific genetic polymorphisms in TNF and HSPA genes may influence KD risk.
  • The decreased frequency of the TNF -238/HSPA1L CG haplotype may confer protection against KD-related inflammation.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.